About PHLCX
PGIM Jennison Health Sciences Fund – Class C is a mutual fund that primarily targets investments within the healthcare sector. Its main objective is to provide capital appreciation by investing in a diversified portfolio of companies spanning across medical and healthcare industries. This fund typically includes businesses involved in pharmaceuticals, biotechnology, medical devices, healthcare service providers, hospitals, managed care, and related fields, thereby covering a broad spectrum of the health sciences landscape. The portfolio is diversified by company size, with significant allocations to giant, large, medium, small, and micro-cap firms, reflecting a balanced approach to sector exposure.
Managed by a team of experienced professionals, the fund seeks to capture growth opportunities arising from advancements in medical technology and evolving healthcare needs. As a sector-specific offering, it plays a specialized role in the financial market, appealing to investors looking for targeted exposure to healthcare trends and innovation. Performance returns and risk metrics are closely compared to health sector benchmarks and the broader market, providing insights into the fund’s competitive standing within its category.
Fund Family PGIM
Category Health
Performance Rating Above Average
Risk Rating Average
Stock Exchange Nasdaq
Ticker Symbol PHLCX
Share Class Class C
Index S&P Composite 1500 Health Care TR
PHLCX had a total return of 14.24% in the past year, including dividends. Since the fund's
inception, the average annual return has been 13.31%.
